THERAPLEX Eczema Therapy
THERAPLEX Eczema Therapy is an FDA drug label for the active ingredient OATMEAL manufactured by THERAPLEX, LLC administered by TOPICAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231204.
- Generic name
- OATMEAL
- Manufacturer
- THERAPLEX, LLC
- Product type
- HUMAN OTC DRUG
- Route
- TOPICAL
- Dosage form
- N/A
- NDC
- 82280-425
- Application
- M016
- Label effective
- 20231204
Active ingredients
Indications & Usage
Uses temporarily protects and helps relieve minor skin irritation and itching due to: • eczema • rashes
Dosage & Administration
Directions apply as needed, or as directed by your doctor.
Contraindications
Not available.
Warnings
Warnings For external use only When using this product do not get into eyes. Stop and ask a doctor if condition worsens symptoms last more than 7 days or clear up and occur again within a few days Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Adverse Reactions
Not available.